| Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma N Auslander, G Zhang, JS Lee, DT Frederick, B Miao, T Moll, T Tian, ... Nature medicine 24 (10), 1545-1549, 2018 | 573 | 2018 |
| WeSME: uncovering mutual exclusivity of cancer drivers and beyond YA Kim, S Madan, TM Przytycka Bioinformatics 33 (6), 814-821, 2017 | 79 | 2017 |
| BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions P Dao, YA Kim, D Wojtowicz, S Madan, R Sharan, TM Przytycka PLoS computational biology 13 (10), e1005695, 2017 | 47 | 2017 |
| CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma M Alon, R Arafeh, JS Lee, S Madan, S Kalaora, A Nagler, T Abgarian, ... Oncotarget 9 (58), 31264, 2018 | 9 | 2018 |
| Using a recently approved tumor mutational burden biomarker to stratify patients for immunotherapy may introduce a sex bias N Sinha, S Sinha, K Cheng, S Madan, A Erez, BM Ryan, AA Schäffer, ... JCO precision oncology 5, 2021 | 4 | 2021 |
| A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials SK Silbert, S Madan, EM Holland, SM Steinberg, L Little, T Foley, ... Blood advances 7 (18), 5566-5578, 2023 | 1 | 2023 |
| Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues N Sanghvi, C Calvo-Alcañiz, P Rajagopal, S Scalera, V Canu, S Sinha, ... bioRxiv, 2023.10. 30.564810, 2023 | 1 | 2023 |
| Repurposing CAR targets in solid tumors from pan-cancer single-cell RNA-seq data S Madan, A Schäffer, E Ruppin Cancer Research 82 (12_Supplement), 2711-2711, 2022 | 1 | 2022 |
| The recently approved high-TMB criteria may introduce a sex bias in response to PD1 inhibitors N Sinha, S Sinha, K Cheng, S Madan, A Schaffer, K Aldape, A Erez, ... Cancer Research 81 (13_Supplement), 29-29, 2021 | 1 | 2021 |
| Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma M Alon, R Arafeh, JS Lee, S Madan, S Kalaora, A Nagler, T Abgarian, ... Oncotarget 10 (13), 1344, 2019 | 1 | 2019 |
| Magnetospectroscopy of CaF2: Dy2+ in the submillimeter∗ J Waldman, RW Stimets, SZ Madan, TS Chang Infrared Physics 18 (2), 141-146, 1978 | 1 | 1978 |
| Abstract LB245: Single cell guided identification of logic-gated cell surface combinations for selective and safe CAR therapy design S Madan, T Chang, B Wang, SR Dhruba, AA Schäffer, E Ruppin Cancer Research 84 (7_Supplement), LB245-LB245, 2024 | | 2024 |
| Unveiling the potential of bispecific antibodies: A comprehensive analysis of efficiency, toxicity, and repurposing in cancer treatment B Wang, S Madan, A Schaffer, E Ruppin Cancer Research 84 (6_Supplement), 871-871, 2024 | | 2024 |
| Cell-type-specific transcriptomic immune aging clocks reveal clinically relevant associations with chronic illnesses including cancer Y Gurevich-Schmidt, K Wang, D Wu, S Madan, V Gopalan, S Sinha, ... Cancer Research 84 (6_Supplement), 1411-1411, 2024 | | 2024 |
| Abstract B100: Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues N Sanghvi, C Calvo-Alcañiz, PS Rajagopal, S Sinha, F Schischlik, ... Molecular Cancer Therapeutics 22 (12_Supplement), B100-B100, 2023 | | 2023 |
| Abstract LB_B06: Single cell transcriptomics guided identification of antigen combinations for the design of logic-gated CAR therapies S Madan, T Chang, B Wang, AA Schäffer, E Ruppin Molecular Cancer Therapeutics 22 (12_Supplement), LB_B06-LB_B06, 2023 | | 2023 |
| Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck Cancer S Madan, S Sinha, T Chang, JS Gutkind, EEW Cohen, AA Schäffer, ... Cancers 15 (19), 4885, 2023 | | 2023 |
| Abstract LB062: Identifying novel targets for CAR-T therapies from single cell RNA-sequencing data S Madan, S Sinha, AA Schäffer, E Ruppin Cancer Research 83 (8_Supplement), LB062-LB062, 2023 | | 2023 |
| IDENTIFYING CELL SURFACE COMBINATIONS FOR TARGETING MALIGNANT PERIPHERAL NERVE SHEATH TUMOR CELLS M Nagy, S Madan, R Vegesna, X Zhang, A Schaffer, E Ruppin, J Shern PEDIATRIC BLOOD & CANCER 69, 2022 | | 2022 |
| Pan-cancer analysis of patient tumor single-cell transcriptomes identifies promising selective and safe CAR targets in head and neck cancer S Madan, S Sinha, SJ Gutkind, EEW Cohen, AA Schäffer, E Ruppin bioRxiv, 2021.09. 29.462485, 2021 | | 2021 |
Eytan RuppinChief, Cancer Data Science Lab (CDSL), NCI/NIHVerified email at nih.gov
